Callery-D'Amico Susan, Sam Leslie M, Grey Timothy H, Greenwood Daniel J
1 R&D Quality Assurance, AbbVie Inc, North Chicago, IL, USA.
2 Global Quality Systems, Eli Lilly and Company Lilly Corporate Center, Indianapolis, IN, USA.
Ther Innov Regul Sci. 2016 Sep;50(5):530-535. doi: 10.1177/2168479016657129. Epub 2016 Jul 28.
Issue management is one of the elements of the TransCelerate clinical quality management (QMS) conceptual framework. Effective issue management benefits clinical development organizations by allowing them to focus efforts on those issues that materially impact patient safety, rights, and well-being; data integrity and/or scientific rigor; compliance with regulatory requirements; or trust in the clinical research enterprise, which have been defined as "Issues that Matter." Issue management begins with a triage of issues to identify those issues that materially impact as defined above, which are then handled by an end-to-end corrective and preventive action (CAPA) process. An added benefit of a well-defined issue management framework is the capability for trending and analytics designed to provide data and insights into risk management and knowledge management efforts.
问题管理是跨加速临床质量管理(QMS)概念框架的要素之一。有效的问题管理使临床开发组织受益,因为它能让组织将精力集中在那些对患者安全、权利和福祉、数据完整性和/或科学严谨性、法规要求合规性或临床研究企业信任产生重大影响的问题上,这些问题被定义为“重要问题”。问题管理始于对问题进行分类,以识别上述产生重大影响的问题,然后通过端到端的纠正和预防措施(CAPA)流程进行处理。定义明确的问题管理框架的另一个好处是具备趋势分析和分析能力,旨在为风险管理和知识管理工作提供数据和见解。